A-share Three Major Indices Fell Collectively, Computing Hardware Active Against the Trend, Hang Seng Tech Index Down Over 1%, AI Large Model Stocks Rebound, KNOWLEDGE ATLAS Rises 7%Wallstreetcn·Apr 9 at 03:19 AM02513+23.20%002793+1.76%
Luoxin Pharmaceutical: The controlling shareholder has partially lifted the pledge of shares and re-pledged themZhitong·Nov 3, 2025 at 02:13 AM002793+1.76%
Luoxin Pharmaceutical: Net profit in the third quarter was 5.2318 million yuan, a year-on-year increase of 102.96%Zhitong·Oct 27, 2025 at 05:50 AM002793+1.76%
The concept of innovative drugs continues to rebound, with GZBL and Luoxin Pharmaceutical both hitting the daily limitZhitong·Oct 15, 2025 at 08:59 PM002793+1.76%002424+0.88%
Luoxin Pharmaceutical issued a profit warning, expecting a net profit attributable to the parent company of 22.7 million to 25.2 million yuan in the first three quarters, turning losses into profitsZhitong·Oct 14, 2025 at 06:06 AM002793+1.76%
Luoxin Pharmaceutical: Han Fengsheng resigns as board secretary, Jiang Ying takes overZhitong·Oct 13, 2025 at 03:55 AM002793+1.76%
Luoxin Pharmaceutical plans to raise no more than 842.4 million yuan through a private placement of sharesZhitong·Sep 29, 2025 at 09:26 AM002793+1.76%
Luoxin Pharmaceutical provides joint liability guarantee for the 10 million debt of its holding subsidiaryZhitong·Sep 11, 2025 at 04:33 AM002793+1.76%
Luoxin Pharmaceutical: Net profit in the first half of 2025 was 17.695 million yuan, a year-on-year increase of 119.95%Zhitong·Aug 27, 2025 at 06:39 AM002793+1.76%
The pharmaceutical sector fluctuates and strengthens, with multiple stocks hitting the daily limitZhitong·Jul 28, 2025 at 09:35 PM300725+4.08%002370+1.68%
Luoxin Pharmaceutical: Daren Management plans to reduce its holdings by no more than 0.97% of sharesZhitong·Jun 12, 2025 at 07:23 AM002793+1.76%
Luoxin Pharmaceutical: Ibuprofen Injection Concentrate Solution Obtains Drug Registration CertificateZhitong·May 27, 2025 at 05:14 AM002793+1.76%
The shareholder cash-out maze of Luoxin Pharmaceutical: Secret clauses suspected of false statements, the "De Yi system" faces repeated setbacks in exitingWallstreetcn·May 20, 2025 at 06:50 AM002793+1.76%
Luoxin Pharmaceutical: Termination of Agreement to Transfer Partial Shares of the CompanyZhitong·May 16, 2025 at 05:45 AM002793+1.76%
Luoxin Pharmaceutical released its first-quarter performance, with a net profit attributable to the parent company of 5.65 million yuan, turning a profit compared to a loss in the same period last yearZhitong·Apr 21, 2025 at 11:41 AM002793+1.76%
